Jun G. Hwang
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Pharmacokinetic evaluation of two oral formulations of chlorpromazine in healthy subjects.
Journal: International journal of clinical pharmacology and therapeutics
Published: May 21, 2026
Pharmacokinetics and Safety of Fixed-Dose Versus Separate Enavogliflozin/Gemigliptin Combinations, and Food Effect on Enavogliflozin in Healthy Korean Subjects.
Journal: Clinical and translational science
Published: April 10, 2025
Impact of Renal Impairment on the Pharmacodynamic and Pharmacokinetic Profiles of Epaminurad, a Novel Uric Acid Transporter 1 Inhibitor.
Journal: Clinical and translational science
Published: February 21, 2025
A First-In-Human Phase 1 Study to Evaluate the Safety and Tolerability of LEM-S401, a Novel siRNA-DegradaBALL Drug Targeting CTGF in Healthy Adults.
Journal: Clinical and translational science
Published: December 27, 2024
Comparison of the pharmacokinetic characteristics and bioequivalence between two nanosuspension formulations of megestrol acetate in healthy Korean male subjects.
Journal: Translational and clinical pharmacology
Published: March 14, 2024
Pharmacodynamics Between a Dual Delayed-Release Formulation of Low-Dose Esomeprazole and Famotidine in Healthy Korean Subjects.
Journal: Clinical therapeutics
Published: March 06, 2024
Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects.
Journal: International journal of clinical pharmacology and therapeutics
Published: June 29, 2023
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 versus reference tocilizumab: a randomized, double-blind, single-dose phase I study.
Journal: Expert opinion on investigational drugs
Published: May 26, 2023
Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject.
Journal: Translational and clinical pharmacology
Published: November 25, 2022
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults.
Journal: British journal of clinical pharmacology
Published: October 11, 2022
Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 24, 2022
Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium-glucose cotransporter 2 inhibitor and metformin in healthy subjects.
Journal: British journal of clinical pharmacology
Published: August 23, 2022
Last Updated: 09/26/2026